MediWound Execs Buy Shares

TL;DR

MediWound CEO & Chairman bought $190.4K in stock on Aug 18th.

AI Summary

On August 18, 2025, MediWound Ltd. reported that its Chairman, Nachum (Homi) Shamir, and CEO, Ofer Gonen, each bought ordinary shares in the company. The total purchase amounted to 11,200 shares at an average price of $17 per share.

Why It Matters

Insider buying can signal confidence from company leadership in future performance, potentially influencing investor sentiment.

Risk Assessment

Risk Level: low — This filing is a routine report of insider share purchases and does not introduce new material risks.

Key Numbers

• 11,200 — Shares Purchased (Total ordinary shares bought by executives.)
• $17 — Average Price (Average price per share paid by executives.)
• $190,400 — Total Value (Calculated total value of shares purchased (11,200 shares * $17/share).)

Key Players & Entities

• MediWound Ltd. (company) — The company making the report.
• Nachum (Homi) Shamir (person) — Chairman of the Board of Directors who purchased shares.
• Ofer Gonen (person) — Chief Executive Officer who purchased shares.
• 11,200 (dollar_amount) — Total number of ordinary shares purchased.
• $17 (dollar_amount) — Average purchase price per share.
• August 18, 2025 (date) — Date of the share purchases.

FAQ

Key Financial Figures

• $17.74 — shares at an average purchase price of $17.74 per share and were conducted in complia

Filing Documents

• zk2533679.htm (6-K) — 9KB
• 0001178913-25-002975.txt ( ) — 10KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2025 Commission File Number: 001-36349 MediWound Ltd. (Translation of registrant's name into English) 42 Hayarkon Street Yavne, 8122745 Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F CONTENTS MediWound Ltd. (the "Company") is filing this Form 6-K to report that on August 18, 2025, Mr. Nachum (Homi) Shamir, Chairman of the Company's Board of Directors, and Mr. Ofer Gonen, the Company's Chief Executive Officer, each individually purchased ordinary shares of the Company in open market transactions. These purchases totaled 11,200 ordinary shares at an average purchase price of $17.74 per share and were conducted in compliance with all applicable requirements of the Company's insider trading policy. The contents of this Report of Foreign Private Issuer on Form 6-K, are hereby incorporated by reference into the Company's Registration Statements on Form S-8 filed with the SEC on April 28, 2014, March 24, 2016, March 19, 2018, March 25, 2019, February 25, 2020, May 15, 2021 August 9, 2022, August 15, 2023, and March 19, 2025 (Registration Nos. No. 333-195517, 333-210375, 333-223767, 333-230487, 333-236635, 333-255784, 333-266697, 333-273997 and 333-285897, respectively) and on Form F-3 filed with the SEC on March 31, 2023, August 29, 2024 and March 19, 2025 (Registration Nos. 333-268297, 333-281843 and 333-285908, respectively). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIWOUND LTD. Date: August 19, 2025 By: /s/ Hani Luxenburg Name: Hani Luxenburg Title: Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR